Intrinsiqq
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. Insider Trading

PMVP

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Sep 2020.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Sep 2020
Sep 25, 2020

Get an email when PMVP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 23, 2025No plan
    Orbimed Capital GP V LLC
    Large holder · sold 1,000,000 at $1.52
    $1.52M
    17% of stake
  • Sep 10, 2025No plan
    Orbimed Advisors LLC
    Large holder · sold 500,000 at $1.80
    900K
    7.7% of stake
  • Jul 1, 2025No plan
    Robert Ticktin
    General Counsel & COO · sold 23,151 at $1.06
    25K
    19% of stake
  • Jul 1, 2025No plan
    Deepika Jalota
    Chief Development Officer · sold 33,065 at $1.06
    35K
    27% of stake
  • Jul 1, 2025No plan
    Michael Carulli
    Chief Financial Officer · sold 28,249 at $1.06
    30K
    32% of stake
  • Jul 1, 2025No plan
    David Henry Mack
    President and CEO · sold 58,411 at $1.06
    62K
    7.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PMVP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PMVP

CompareIntrinsic value
ATOSAtossa Therapeutics Inc
$1.60-8.86%10
COYACoya Therapeutics Inc.
$2.95-1.01%10
XLOXilio Therapeutics, Inc.
$7.56+0.67%50
ABUSArbutus Biopharma Corporation
$4.02-1.23%84
UPBUpstream Bio, Inc.
$1.59-20.50%21
OVIDOvid Therapeutics Inc.
$2.20-5.98%10
LQDALiquidia Corporation
$54.43-3.88%63
PCRXPacira BioSciences Inc.
$36.48+0.00%61

Held by ETFs

PMVP is in 1 US ETF. The largest of them, with PMVP's weight in each:

Spot a number that looks wrong? Check it in PMVP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PMVP

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.